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ORIGINAL ARTICLE
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Background: An increasing number of currently used pesticides are reported to possess oestrogen-like
properties or to disturb the endocrine system in other ways.
Objectives: To investigate if xeno-oestrogenic activity in serum can be used as a biomarker of the combined
exposure to pesticides with oestrogen-like properties in an occupational setting.
Methods: Serum samples were obtained from two separate cohorts representing non-pregnant and pregnant
female greenhouse workers in Denmark. Serum samples from 270 non-pregnant women and 173 pregnant
women were analysed for xeno-oestrogenic activity. A fraction containing major xeno-oestrogens but without
pharmaceutical and endogenously produced oestrogens was isolated from each serum sample by solid-
phase extraction and tested for oestrogenic response in a MCF-7 cell proliferation assay. The pesticide
exposure for each woman was categorised as low, medium or high based on information collected by
detailed interviews of the women and the employers.
Results: In both cohorts, an exposure-associated increase in the xeno-oestrogenic activity in serum was
demonstrated. Among the pregnant women, the association between pesticide exposure and xeno-
oestrogenic activity in serum was statistically significant for women who had been at work within the last
week, while no association was observed for women who had not been at work during the most recent week.
Conclusions: The study illustrates the usefulness of this biomarker for qualitative assessment of the combined
exposure to mixtures of oestrogen-like pesticides. Although the individual pesticides responsible for the xeno-
oestrogenic response were not identified, the study demonstrates that, even within highly-controlled
greenhouse operations, occupational exposure to oestrogen-like pesticides can result in detectable impacts on
hormonal activity in the blood.
E
xposure situations are often complex and involve several
potentially interacting chemicals. Compounds with the
same mode of action are likely to be additive.1–3
Development and use of exposure biomarkers is a valuable
tool in environmental epidemiology, and a promising approach
to complex exposures is to use biomarkers that integrate the
response from several substances that affect the same target.
Based on strong evidence from studies in wildlife and
laboratory animals, there is increasing concern that exposure
to endocrine disrupting chemicals may impair reproductive
capability, disturb fetal development, and promote carcinogen-
esis in humans.4–6 A biomarker assessing the total exposure to
xeno-oestrogens in serum samples was initially developed by
Soto and Sonnenschein7 8 and this methodology has since been
refined and used for measurement of the xeno-oestrogenic
response in adipose tissue9 or in serum samples10–12 from
populations with increased exposure to persistent, lipophilic
pollutants. The approach used in this biomarker assay includes
extraction of oestrogens from serum samples followed by
separation of xeno-oestrogens from endogenous oestrogens,
and the oestrogenic activity of the xeno-oestrogen fraction (XE
fraction) is then determined in vitro. The focus so far has been
on lipophilic, non-polar pollutants that are easily separated
from the endogenous and pharmaceutical oestrogens. However,
several polar substances, including some of the currently used
pesticides, are also thought to possess oestrogenic properties in
vitro13–15 and in vivo.16 The aim of this study was to investigate
whether the biomarker approach for serum xeno-oestrogenic
activity could be used to assess the mixed exposure to
potentially oestrogenic pesticides in an occupational setting.
We chose to examine female greenhouse workers in Denmark,
where exposures generally are well controlled, although current
safety procedures are not specifically aimed at preventing
exposures to endocrine disruptors.
METHODS
Study design and participants
The study is based on two independent cohorts of female
greenhouse workers.
Cohort 1: non-pregnant female greenhouse workers
A cohort of female greenhouse workers was established from
February 1996 to December 1997 in a cross-sectional study
design. A letter of invitation was sent to all greenhouse owners
on the island of Funen, Denmark to obtain permission to visit
the greenhouses and to invite the female employees for
participation in the study. Among the 220 greenhouse
horticultures on Funen, 100 (45%) of the owners agreed to
participate after telephone contact, whereas 35% did not meet
the inclusion criteria (no female employees), and 20% chose not
to participate. Thus, 69% of the eligible employers agreed to
participate in the study. All female employees at the 100
greenhouse horticultures were informed orally and in a letter of
invitation about the project. Among the women working in the
greenhouses 602 agreed to participate and gave written
consent; based on union records and information from
employers, the participants correspond to about 75% of the
eligible women. Interview-assisted questionnaires and blood
Abbreviations: HPLC, high performance liquid chromatography; E2, 17b-
oestradiol; PPE, personal protective equipment; RPE, relative proliferative
effect; XE fraction, xeno-oestrogen fraction
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samples were collected at the workplace. Blood samples were
successfully obtained from 571 (95%) of the participants.
Cohort 2: pregnant greenhouse workers
Pregnant women employed in greenhouses on Funen were
recruited consecutively from July 1996 to October 2000 at the
Department of Occupational and Environmental Medicine at
Odense University Hospital. A previous survey (unpublished
data) indicated that approximately 50% of all pregnant women
working in greenhouses on Funen were referred by their
general practitioner to the hospital department to receive advice
regarding working conditions during pregnancy. In an attempt
to increase the percentage of referred pregnant greenhouse
workers, information on the study was sent to all general
practitioners and owners of greenhouse horticulture industries
on Funen. During the inclusion period, a total of 336 pregnant
greenhouse workers were referred to the department. After oral
and written information about the study, acceptance and
written consent was obtained from 289 women (representing
314 pregnancies); that is, 93% of the total number referred. One
woman was included with three separate pregnancies, 23
women participated with two separate pregnancies, and the
remaining 265 women participated only once. All interviews
were performed at the department of Occupational and
Environmental Medicine. In most cases the women were in
first trimester at the time of referral with a mean of gestational
week 7 (range 1.5–26). After the interview the women were
asked to deliver a blood sample, which were collected at the
hospital immediately after the interviews. Blood samples
representing 239 of the 314 pregnancies (76%) were success-
fully obtained.
The study was conducted according to the Helsinki II
Declaration and was approved by the regional ethical review
committee and the Danish Data Protection Agency. In both
cohorts the women were included after providing informed
written consent.
Exposure information
The participants of both cohorts underwent a structured
interview with detailed questions about working conditions
during the last three months. The information included average
weekly working hours, a description of job functions and
average weekly time used for each function, personal handling
of pesticides (for example, application and mixing), re-entry
intervals before entering greenhouses where pesticides had
been applied, procedure for handling of plant cultures recently
treated with pesticides, and the use of personal protective
equipment. The women were also asked about the type of
pesticide products and frequency of use both in the relevant
working areas and in the greenhouse as a whole. Further, the
women were asked about educational background, smoking
habits, non-occupational exposure to pesticides (used at home
for pets or during gardening), and use of pharmaceutical
hormones including oral contraceptives or other products
containing oestrogen.
The information about use of pesticides obtained from the
interview was supplemented with information from the
employers. We asked the employer for detailed information
on the use of pesticides during the last three months. For the
cohort of non-pregnant women this information was, in most
cases, provided as copies of the logbooks, in which all pesticide
use (date of application, area treated, trade name of the
pesticide product and the concentration applied) must be
registered according to Danish law. For the cohort of pregnant
women, the employers were contacted by telephone to obtain
more detailed information about actual and recent pesticide use
in the area where the woman had been working.
Based on the information from the women and the employ-
ers, the pesticide exposure level for each woman was
categorised as low, medium or high. All exposure ratings were
performed in parallel and independently by two toxicologists
with special expertise in horticulture working conditions and
these ratings were completed before the assessment of xeno-
oestrogenic activity in the serum samples. Initially, all work
functions were scored according to potential pesticide contact.
Application and mixing of pesticides and dipping of cuttings
directly into pesticide solutions were assigned a high score. Re-
entry activities with intensive plant contact (for example,
nipping cuttings or propping up the plants) had a medium
score, and re-entry activities with minimal plant contact (for
example, moving of pot plants and packing) had a low score.
Scores for the different work functions were developed in
collaboration with representatives of greenhouse owners and
the Danish labour union for greenhouse workers. Exposure
ratings for each woman were obtained by combining the work
function scores with information about the average weekly
time spent on the different work functions, the use of personal
protective equipment (PPE) and the information about when
and how often pesticides had been applied in the working area
or on the plants handled by the woman. Hence, for women who
had direct contact with pesticides by applying, mixing or
dipping cuttings in pesticides, the exposure level was rated as
high or medium depending on the exact procedure, the
duration of the process, and the use of PPE. For the re-entry
activities, the exposure was rated as high if pesticides were used
frequently (more than once a week) in the working area and
the woman often handled treated plants without using gloves
and had other work functions with intensive plant contact.
Exposure was rated as low if pesticides had not been applied in
the working area and the woman had not handled plants that
had been treated with pesticides within the last three months.
The low exposure groups can therefore be considered as
internal non-exposed control groups. Exposures were rated as
medium if pesticides were used in the working area only
infrequently (less than once a week), if intensive plant contact
occurred or if pesticides were used frequently, but without
contact with plants within 24 h after treatment (table 1).
Blood samples
Venous blood samples were collected into plain Venoject tubes
(Terumo Europe NV, Leuven, Belgium) during the day time
(between 09:00 and 16:00). One hour after sampling, the blood
samples were centrifuged to separate the serum. Within 4 h
after sampling, the serum was frozen in 1 ml aliquots in Cryo
tubes (Greiner, Frickenhausen, Germany) at 280 C˚ until use.
Due to the labour intensity of the biomarker method,
subgroups of samples were selected for analysis. From the
cohort of non-pregnant women, 270 serum samples (out of
571) were selected. The samples include all blood samples
obtained from the low and high exposure groups. From the
medium exposure group, 119 serum samples (out of 420) were
selected to represent smokers, non-smokers, and users and
non-users of oral contraceptives within this exposure group.
For the 270 women included in the analysis of xeno-oestrogenic
activity, the median age was significantly lower in the medium
and high exposure groups than in the control group (table 2).
There were significantly fewer smokers in the medium
exposure group and more users of oral contraceptives in the
high exposure group compared to the control group. Only a few
women from each exposure group used hormone-containing
pharmaceuticals (mainly hormone replacement therapy) other
than oral contraceptives.
From the cohort of pregnant women, blood samples from 173
pregnancies were analysed for xeno-oestrogenic activities. The
Serum oestrogenic activity and pesticide exposure 709
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samples represent all blood samples obtained from women
whose pregnancies resulted in one or more live born children.
Among these women, there was no significant difference in
median age and number of smokers between the exposure
groups. Gestational week at sampling was significantly lower in
the highly exposed group (table 2), possibly due to earlier
referral. Only three women, all in the medium exposure group,
used hormone-containing pharmaceuticals (progesterone sup-
plement).
Analytical methods
Xeno-oestrogenic activity in serum samples
Xeno-oestrogenicity in serum was measured as previously
described10 with minor modifications in order to allow inclusion
of pesticides relevant to these cohorts. Briefly, xeno-oestrogens
were extracted from 4 ml of serum by solid-phase extraction
(OASIS HLB 6cc 500 mg extraction cartridge from Waters,
Milford, MA, USA). The extracted compounds were separated
by high performance liquid chromatography (HPLC) to collect a
fraction including major xeno-oestrogens (XE fraction), while
avoiding pharmaceutical and endogenous oestrogens. This
fraction was then tested for oestrogenic response in the MCF-
7 cell proliferation assay. In our previously described method,10
we sampled the HPLC fraction eluting within the first 5.5 min.
In the present study, we expanded the sampling period to
8.0 min in order to include more hydrophilic pesticides. This
fraction included, in addition to the compounds previously
described,10 a wide range of pesticides, for example, dieldrin
(1.75 min), endosulfan (1.83+3.87 min), chlorpyrifos
(1.94 min), deltamethrine (2.07+3.22 min), methoxychlor
(2.18+2.72 min), methiocarb (5.36 min), vinclozolin
(5.8 min), pirimicarb (6.19 min), and fenarimol (7.76 min).
As before,10 subfractions of serum from the pregnant women
were excluded to avoid pregnancy-related hormones. In the
present study, an additional subfraction from 6.2–7.1 min was
eliminated to avoid pregnenolone. To calibrate and adjust time
windows for collection of the HPLC fractions, a standard
mixture, including vinclozolin, fenarimol, 5a-dihydroprogester-
one, pregnenolone, testosterone and oestrone was run before
each sample series.
Testing of the XE fraction in the MCF-7 cell proliferation
assay was performed as previously described.10 To allow
determination of both an agonistic and an antagonistic
response in the proliferation assay, the serum extracts were
analysed with and without concomitant addition of 10 pM 17b-
oestradiol (E2). This E2 concentration induces approximately
half of the maximum response in the proliferation assay. Due to
insufficient serum volume, 15 serum samples (1 control and 14
exposed) were not tested together with E2.
The MCF-7 cell proliferation assay results are expressed as
the number of cells after six days of incubation with the test
substance. This response was adjusted for the result of negative
control samples (cells treated with oestrogen-free medium
supplemented with solvent only) in each analytical run to
Table 1 Criteria for rating exposure levels
Work function Low (controls) Medium High
Application of
pesticides
No Infrequently irrigating plants, dipping of
cuttings in pesticides using PPE
Mixing and spraying pesticides OR
frequently irrigating plants AND/OR
dipping cuttings in pesticides without
using PPE
Re-entry No pesticides applied in
the working area AND
no handling of treated
plants within the last
3 months
1. Pesticides applied in working area
.1/week AND intensive contact to
treated plants using PPE, OR
2. Pesticides applied in working area
.1/week AND minor contact with
treated plants with or without using PPE,
OR
3. Pesticides applied in working area
,1/week AND intensive contact to
treated plants with or without using PPE
Pesticides applied in working area
.1/week AND intensive contact to
treated plants without using PPE
PPE, personal protective equipment.
Table 2 Distribution of age, smoking, oral contraceptive usage, hormone pharmaceutical
usage*, and gestational week at sampling among three exposure groups of female greenhouse
workers
Low (controls) Medium High
Non-pregnant women
Sample size, n 58 119 93
Age (years)
Median (25th–75th percentiles) 42.6 (33.0–48.6) 34.2 (27.7–43.9) 29.3 (23.6–41.2)
Smokers, n (%) 20 (34.5) 19 (16.0) 31 (33.3)
Oral contraceptive use, n (%) 12 (20.7) 23 (19.3) 38 (40.9)
Hormone treatment, n (%) 6 (10.3) 5 (4.2) 5 (5.3)
Pregnant women
Sample size, n 29 88 56
Age (years),
Median (25th–75th percentiles) 26.7 (25.2–28.5) 27.3 (24.8–30.3) 27.5 (25.7–29.7)
Smokers, n (%) 13 (44.8) 27 (30.7) 16 (28.6)
Hormone treatment, n (%) 0 3 (3.4) 0
Gestational week at sampling
Median (25th–75th percentiles) 5.9 (5.1–8.3) 6.6 (5.1–8.7) 5.2 (4.3–7.0)
*Hormone containing pharmaceuticals other than oral contraceptives.
p,0.05 compared to low exposed controls.
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account for differences in the initial seeding density. All serum
extracts were analysed in triplicate and the coefficient of
variation (CV) within each run was below 5%. The inter-assay
variation for all the series was 14%. All results are given as the
relative proliferative effect (RPE) compared to the maximum
E2 response:
RPE = [(PEtest sample-1)/(PEmaxE2-1)] 6 100
where PE is the response normalised to controls. Thus, the RPE
describes the efficacy of the test sample to induce cell
proliferation relative to that of E2. Within each cohort the
samples were analysed without information on exposure status
or other predictors and in random order.
Statistics
Pesticide exposure was categorised as low (control), medium,
or high as described above. Potential confounders identified
from a priori considerations of factors that might influence
xeno-oestrogenic response included age, smoking, actual use of
oral contraceptives (non-pregnant women) or other hormone
containing pharmaceuticals, and gestational week at sampling
(pregnant women). Differences in the distribution of these
covariates between the exposure groups were compared by
using the non-parametric Mann-Whitney test. Data on xeno-
oestrogenic and xeno-antioestrogenic activities as well as age
and gestational week at sampling were not normally distrib-
uted, and the median and interquartile range (25th–75th
percentiles) was therefore calculated. Further, negative values
of the xeno-oestrogenic and anti-oestrogenic activities were
substituted by 0.01 RPE. The data, along with age and
gestational week, were then transformed using the natural
logarithm to approach a normal distribution. A multiple linear
regression analysis was performed taking into account the
potential confounders mentioned above. Pesticide exposure,
smoking, and oral contraceptive and other hormone pharma-
ceutical usage were entered into the model as dummy variables.
RESULTS
The data from the two cohorts of female greenhouse workers
were analysed separately as the HPLC fraction containing
pregnenolone had been removed from the serum samples from
the pregnant women, but not from the non-pregnant women.
For all women, re-entry activities (such as moving or packing
pot plants or nipping cuttings) constituted the main work
functions. Besides, 17% of the women in the cross-sectional
cohort and 23% in the cohort of pregnant women reported to
have been directly involved in applying pesticides mainly by
irrigating fungicides or growth retardants.
In both cohorts of female greenhouse workers, an exposure-
associated increase in xeno-oestrogenic activity was observed
(tables 3 and 4). Of the possible confounders included in the
multiple regression analyses, only gestational week at sampling
significantly affected (increased) the xeno-oestrogenic activity
in serum. After confounder adjustment, the xeno-oestrogenic
activity was still positively associated with the level of pesticide
exposure in both cohorts (table 4), although the xeno-
oestrogenic activity in the medium exposed group of pregnant
women was not significantly higher than the control group.
Gestational week at sampling was lower for the group of
pregnant women with high pesticide exposure compared to the
medium and low exposure groups (table 2). This could lead to a
lower xeno-oestrogenic response in the high exposure group
and hence underestimate the difference between the groups
and might be one explanation for the more marked effect of
confounder adjustment among the pregnant women (table 4).
Additionally, most of the pregnant women (77%) had been
absent from work for some time before blood sampling, in
accordance with the general recommendation to refrain from
possibly hazardous procedures until the working conditions
had been assessed by the occupational health specialists. The
exposure-free period varied from a few days to several weeks.
As the pesticides used in the working areas are non-persistent
and assumed to be metabolised and excreted within few days,
the regression analyses were repeated separately for those
women who had been at work and those who had not been at
work within the last week before blood sampling. For eight
women information about last working day was missing, and
they were therefore excluded from this analysis. A strong
association between xeno-oestrogenic activity and pesticide
exposure was seen for the women who had been at work within
the last week, while no such association was observed for the
women not at work during the most recent week.
Irrespective of pesticide exposure level, the response obtained
from serum samples from non-pregnant women was lower
than the response obtained from serum samples from pregnant
women (table 3). This tendency was also seen when the serum
samples were tested together with 10 pM E2 to assess
antagonistic or potentiating effects. For the pregnant women,
the response obtained in the presence of E2 was higher than the
response induced by E2 alone (table 5). However, for the non-
pregnant women, the E2-induced response was reduced, thus
indicating an anti-oestrogenic effect of the serum extract. For
none of the two cohorts did the response in the presence of E2
differ between the pesticide exposure groups (table 5). Multiple
linear regression analyses, taking into account the confounders
Table 3 Xeno-oestrogenic activity* in serum from female greenhouse workers exposed to
different levels of pesticides
Median RPE (25th–75th percentiles)
Low (controls) Medium High
Non-pregnant women 3.2 (1.8–4.9) 4.0 (2.2–6.3) 3.8 (2.7–4.9)
n 58 119 93
Pregnant women (all) 6.0 (2.5–8.1) 7.2 (4.7–11.2) 7.6 (5.4–11.8)
n 29 88 56
Pregnant women who had been working during
the previous week
5.2 (0.6–6.8) 8.8 (5.5–15.3) 7.7 (5.3–11.0)
n 12 29 29
Pregnant women who had not been working
during the previous week
6.3 (2.9–8.3) 6.3 (3.7–9.5) 7.0 (5.4–12.2)
n 16 55 24
RPE (relative proliferative effect) = [(PEtest sample-1)/(PEmaxE2-1)]6100, where PE is the response normalised to controls;
n, number of serum samples analysed.
*Data represent RPE obtained for the XE fractions isolated from 4 ml of serum and tested in the MCF-7 cell proliferation
assay.
Serum oestrogenic activity and pesticide exposure 711
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mentioned before, also did not indicate any exposure related
effect on the serum response after co-exposure with E2 (data
not shown).
DISCUSSION
The present study demonstrates an exposure-related increase in
xeno-oestrogenic activity of serum obtained from two cohorts
of women occupationally exposed to pesticides in greenhouses.
This finding is difficult to relate to individual substances,
because the major part of currently used pesticides has not yet
been investigated for endocrine disrupting activities. However,
screening studies using cellular assays indicate that a consider-
able part of these pesticides possess endocrine disrupting
properties, whether by activating the oestrogen receptor,
blocking the androgen receptor and/or by interfering with
enzymes involved in the metabolism of steroid hormones13 15 17
Although the potencies of the pesticides as hormone agonists or
antagonists are low when compared to the natural ligands,
effects of pesticides with the same mode of action are likely to
be additive, and the integrated response from mixed pesticide
exposure is therefore of interest. Additive effects of oestrogenic
acting pesticides have been demonstrated in vitro in several
studies.3 18 If the concentration-response curves are sigmoid, a
combined effect of low concentrations of several oestrogenic
pesticides can induce a marked response, even though the
response induced by the individual compounds may be below
the detection limit.
This study demonstrates the usefulness of this biomarker for
qualitative exposure assessment of oestrogenic pesticides at the
group level. The biomarker has the additional advantage of
being fairly independent of confounders. However, the wide
variation in xeno-oestrogenic activity within the groups,
including the control group, suggests that the biomarker
cannot be used for quantitative exposure assessment at the
individual level. Although some of the inter-individual varia-
tion within the exposed groups could be explained by
individual differences in exposure level and pesticides used,
some of the variation is likely the result of exposure to
oestrogenic compounds from other sources—for example, food
and cosmetics.
In general, the xeno-oestrogenic response did not differ
much between the medium and high exposure groups,
Table 4 Unadjusted and adjusted results* from linear regression analyses of xeno-
oestrogenic activity in serum among female greenhouse workers exposed to pesticides
compared to unexposed/low exposed greenhouse workers
Change in xeno-oestrogenic activity (%) b (95% CI)
Low (controls) Medium High
Non-pregnant women
Unadjusted results Reference 41 (12 to 70) 45 (15 to 75)
Adjusted results 58 (26 to 90) 57 (22 to 92)
Pregnant women (all)
Unadjusted results Reference 76 (9 to 143) 176 (105 to 247)
Adjusted` results 60 (26 to 126) 204 (133 to 275)
Pregnant women who had been working during
the previous week
Unadjusted results Reference 409 (308 to 510) 429 (328 to 530)
Adjusted` results 403 (301 to 505) 567 (463 to 671)
Pregnant women who had not been working
during the previous week
Unadjusted results Reference 211 (2103 to 81) 94 (210 to 198)
Adjusted` results 224 (2116 to 68) 87 (217 to 191)
*The data shown in the table are % change in xeno-oestrogenic activity in the high and medium exposed groups
compared to the low exposed group (reference value).
Adjusted for age, use of oral contraceptives, use of hormone containing pharmaceuticals (other than oral
contraceptives), and smoking.
`Adjusted for age, gestational week at sampling, use of hormone containing pharmaceuticals (other than oral
contraceptives) and smoking.
Table 5 Xeno-oestrogenic response* when serum samples from female greenhouse workers
were tested together with E2
% of the response induced by 10 pM E2 alone, median (25th–75th
percentiles)
Low (controls) Medium High
Non-pregnant women 75 (63–83) 77 (59–104) 76 (65–90)
n 57 106 92
Pregnant women (all) 131 (124–141) 133 (122–145) 134 (123–147)
n 29 88 56
Pregnant women who had been working during
the previous week
132 (124–142) 135 (122–147) 133 (123–148)
n 12 29 29
Pregnant women who had not been working
during the previous week
129 (122–140) 132 (122–143) 133 (123–147)
n 16 55 24
n, number of serum samples analysed.
*Results represents data obtained for the XE fractions isolated from 4 ml of serum and tested together with 10 pM E2 in
the MCF-7 cell proliferation assay. They are expressed as percentages of the response obtained by 10 pM E2 alone.
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presumably because exposure rating is fraught with difficulties
when individual behaviour characteristics play a major role. For
example, individuals considered highly exposed with direct
contact with pesticides or newly treated plants may not
necessarily be highly exposed if they are more aware of the
hazard and adjust their work habits to minimise the exposure.
For all exposure levels, the xeno-oestrogenic responses in
pregnant women were considerably higher than those from the
non-pregnant women. Likewise, a lower response from non-
pregnant women was obtained when the serum was tested
together with 10 pM E2, thus supporting a lower responsive-
ness of the cells. As the exposure situation for the two cohorts
was very similar, the reason for this difference could be
attributed to slight differences in assay sensitivity over time.
The serum samples from the cohort of non-pregnant women
were analysed approximately one year before the samples from
the cohort of pregnant women. Although the procedure is
standardised and the response is normalised to control
(unexposed cells) and to the maximal response induced by
E2 (positive control), some change in the responsiveness of the
assay over time is unavoidable. An additional consideration is
that, although all known endogenous compounds with
oestrogenic activity were removed from the serum, some
unidentified endocrine metabolites produced during pregnancy
could remain in the serum fraction analysed and have
contributed to a higher response. This possibility would then
also explain the tendency of an increased xeno-oestrogenic
activity at increasing gestational week. A tendency towards
higher xeno-oestrogenic responses among pregnant women
compared to non-pregnant women was also observed within
the control group from our previous study,10 where xeno-
oestrogenic activity in serum samples from pregnant Faroese
women exposed to polychlorinated biphenyls and other
persistent pollutants was compared with the xeno-oestrogenic
activity among Danish pregnant and non-pregnant controls.
Hence, fractionating of the serum samples from pregnant
women may have to be further refined to avoid interference
from pregnancy-related hormonal substances. In contrast, among
non-pregnant women, the use of oral contraceptives or other
hormone-containing pharmaceuticals did not affect the xeno-
oestrogenic response, thus indicating that all pharmaceutical
oestrogens had been effectively removed from the serum.
The difference in response level between the two cohorts did
not prevent the ability to demonstrate an exposure-related
increase in xeno-oestrogenic activity in the two different
cohorts. Among the pregnant women the presence of an
exposure-related increase in xeno-oestrogenic activity only in
serum from the women who had been at work during the
previous week strongly supports the notion that the response is
directly related to the occupational pesticide exposure. The
absence of exposure-related differences when co-tested with E2
is in agreement with the fact that only one pesticide so far has
been identified as an oestrogen antagonist.10
The exact pesticides responsible for the xeno-oestrogenic
activity cannot be identified from this study. The women were
exposed to a wide range of pesticides, of which only a minor
part has been tested for endocrine disrupting properties. In a
sub-analysis, women with medium or high exposure to known
pesticides with demonstrated oestrogenic properties (chlorpyr-
ifos, deltamethrin, endosulfane, fenarimol, methiocarb, tochlo-
fos-methyl)13 had higher xeno-oestrogenic activity than
unexposed controls (data not shown). However, the response
of these women did not differ from the one seen in the group of
women exposed to other pesticides—that is, including sub-
stances with unknown oestrogenic potentials.
Worldwide, many women of child-bearing age are working in
occupations using pesticides and they are therefore potentially
exposed to endocrine disrupting compounds. Since the devel-
oping fetus is particularly vulnerable to endocrine disrupting
substances, it is crucial to protect pregnant women against such
exposures. This study demonstrates that occupational exposure
to oestrogenic pesticides does occur, even under circumstances
where strict controls and hygiene procedures must be
respected. Therefore, pregnancy outcomes and the health status
of children of women potentially exposed to pesticides in their
workplace should be carefully monitored to ensure that
appropriate measures are taken to prevent adverse health
effects. Better guidance in the use of protective equipment,
especially in relation to re-entry activities, as well as prolonged
re-entry intervals, is expected to reduce the exposure levels.
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Main messages
N Most currently used pesticides have yet to be examined
for endocrine disrupting activities, although cell-based
assays indicate that a considerable number may possess
endocrine disrupting properties.
N A biomarker method for assessing xeno-oestrogenic
activity of human serum can be applied to estimate the
combined impact of mixed exposures to pesticides.
N Examination of two groups of female greenhouse work-
ers has shown an exposure-related increase in xeno-
oestrogenic activity in serum.
N A clear association between pesticide exposure and
xeno-oestrogenic activity in serum was observed among
women who had been at work in greenhouses during the
previous week, while no such association was observed
for those absent during the past week or longer. This
finding supports the validity of the association between
occupational pesticide exposure and xeno-oestrogenic
response in serum, and suggests that it is primarily
dependent on recent exposures.
N The results obtained show that occupational exposure to
pesticides may cause endocrine changes, despite strict
controls and hygiene procedures used in greenhouses.
Policy implications
N The developing fetus is considered particularly vulnerable
to endocrine disrupting substances, and female workers
must therefore be protected from exposure to such
compounds, including pesticides with oestrogen-like
activities.
N Many pesticides have been shown to possess endocrine
disrupting properties in cell-based studies, and their
possible impact on human health deserves attention.
N Improved safety at work, including use of protective
equipment in relation to re-entry activities, as well as
prolonged re-entry intervals, may reduce the exposure
level to approved pesticides.
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